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The purpose of this study will be to review the outcome of a subtotal capsulectomy of the hip for 
idiopathic chondrolysis.  We plan to review the imaging (radiographs, CT scans and MRI scans), 




Idiopathic chondrolysis of the hip is a very rare condition.  It is characterized by cartilage necrosis of 
the hip joint not associated with trauma, SUFE, infections or other demonstrable causes.  It was first 
described in 1971 by Jones from the Princess Alice Orthopaedic Hospital in Cape Town. 
 
It occurs mainly in adolescent girls.  The outcome in South Africa has been reported as a progressive 
downhill course resulting in a painful, stiff hip.  The aetiology of the  
disease remains unknown.  Theories suggested are mechanical (decreased movement with loss of 
synovial nutrition; increased joint pressure) and an auto-immune response in genetically 
predisposed individuals. 
 
The differential diagnosis includes atrophic-type tuberculosis of the hip. 
 
Suggested treatment ranges from NSAIDs and range of motion exercises alone to early aggressive 
surgical treatment.  Our experience with continuous passive motion (CPM) and NSAID treatment 
have been disappointing. 
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In 1988 Roy and Crawford described a subtotal capsulectomy of the affected hip with concomitant 
muscle releases to relieve intra-articular pressure and correct muscle contractures. 
This treatment was tried at our unit with encouraging results.  In 2011 a treatment protocol was 
started that involved: 
 Pre-op
o Routine blood work-up and Mantoux skintest to rule out TB
o Radiographs, CT scan and MRI scan of the affected hip for diagnosis
o Trial of non-operative management:  NSAID’s, traction and CPM
 Subtotal capsulectomy with muscle releases if no response to non-operative management
o Histology and culture of synovium and cartilage to confirm diagnosis
 Post-op
o NSAID’s and CPM
o Follow up radiographs and MRI scan to assess disease progression
Subsequently we’ve performed 5 such cases with biopsy of the affected cartilage at the same time. 
We want to assess the outcome of this treatment. 
Materials and Methods 
Study design 
This will be a retrospective cohort study.  We will perform a retrospective review of prospectively 
collected data on these patients. 
Study population 
Inclusion criteria 
All patients that had a subtotal capsulectomy of the hip performed for idiopathic 
chondrolysis from January 2011 to August 2012. 
Exclusion criteria 
All patients with less than 6 months follow up after surgery. 




The theatre records at Maitland Cottage Hospital will be used to identify the patients from January 
2011 to August 2012. 
 
Data collection 
The patients’ hospital folders will be accessed and the orthopaedic notes will be used to collect the 
relevant clinical data.  Laboratory results will be collected from the electronic National Health 
Laboratory System.  Images will be reviewed on the electronic Picture Archiving and Communication 
System (PACS). 
 
The following data will be collected from the folders 
 Demographic information:  Age, gender 
 Presenting symptoms and duration 
 Clinical findings at presentation, specifically pain and range of motion of the hip 
 Results of laboratory tests 
 Findings of imaging, including radiographs, computed tomography (CT) scans and magnetic 
resonance imaging (MRI) scans 
 Details of surgery performed 
 Results of histology of cartilage biopsy 
 Clinical findings at final follow up, specifically pain and range of motion of the hip 
 Findings of follow up imaging 
 
Data analysis 
After collection Microsoft Excel tables and graphs will be used to for data capturing and analysis. 
 
 
Risks and benefits 
There will be no risk to the participants as this is a retrospective review of investigations and 
procedures already performed.  No additional investigations or procedures will be performed. 
 
Benefits would include measuring the outcome of procedures performed in our unit and being able 
to compare this to international literature.  We would be able to review our practise and better 
inform future patients of the expectant outcome of the surgery.  We would also be able to 





No consent will be obtained as this is a retrospective review of cases already performed. 
 
 
Privacy and confidentiality 
Privacy and confidentiality of all data and results will be ensured.  All data is delinked once we have 
completed data collection, but obviously as the treating surgeon we will recognise the pathology so 
anonymity is limited.  We never put names in our presentations or publications. 
 
 
Outcome of study 
Our aim would be to publish our results in a paediatric orthopaedic journal for peer review.  We also 
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Subtotal capsulectomy for idiopathic chondrolysis of the hip 




Idiopathic chondrolysis (IC) of the hip is a very rare, crippling condition affecting mainly adolescent 
females with fewer than 130 cases documented.1  It is characterized by rapid cartilage necrosis of 
the hip joint, not associated with trauma, slipped upper femoral epiphysis (SUFE), infection or other 
demonstrable causes.2  Patients present with insidious onset of pain, a limp and a typical flexion, 
abduction and external rotation deformity of their hip joint and radiological loss of joint space of the 
affected hip. 
 
The natural history ranges from complete recovery to painful ankylosis.1  Management remains 
controversial and various treatment strategies have been advocated.  Non-operative treatment with 
non-steriodal anti-inflammatory drugs (NSAIDs), non-weightbearing and physiotherapy, including 
continuous passive motion (CPM), are used.3–5  Aggressive operative treatment has also been 
described.  In 1988 Roy and Crawford reported on a subtotal capsulectomy with soft tissue releases 
followed by aggressive rehabilitation.6  Three cases were treated with good results.  Subsequent 




The objectives of this literature review are to: 
 Clarify the definition, epidemiology, aetiology, patho-anatomy, clinical and radiographic 
features and natural history 
 To research the treatment options used and critically analyse the outcomes of these 
described methods 







Google Scholar and Pubmed internet search engines were used to search online databases.  Review 
articles on the subject were analysed and their references were research.  The section on idiopathic 
chondrolysis in the chapter on other conditions of the hip in Lovell & Winter's Pediatric 
Orthopaedics, 6th Edition2 was also reviewed and the relevant references researched.  All available 
evidence was screened and the relevant articles were obtained from the University of Cape Town 
library. 
 
When searching ‘idiopathic chondrolysis of the hip’ on Google Scholar 951 articles are cited.  The 
same search on Pubmed cites 38 articels.  Similar searches for ‘idiopathic chondrolysis managed by 
subtotal capsulectomy’ yielded 22 and 1 articles respectively. 
 
Quality of evidence 
The evidence on the topic is limited to case studies and small case series.  All the studies can be 




Summary of literature 
Background 
Waldenström first described chondrolysis of the hip joint.8  It has been described secondary to a 
variety of conditions, including SUFE, trauma, septic arthritis, severe burns, prolonged 
immobilization and even Marfan and Stickler syndromes.1  The term idiopathic chondrolysis refers to 
chondrolysis where a demonstrable cause cannot be identified. 
 
IC was first described in 1971 by Jones from the Princess Alice Orthopaedic Hospital in Cape Town.  
He reported on a series of 9 adolescents (8 girls and 1 boy) with hip joint disease that did not 
conform to other known conditions and that presented with consistent enough clinical pictures to 
justify the recognition of a distinct clinical entity.9  In 1982 Sparks and Dall from the same unit 
reported on the original series and a further 9 patients.  They confirmed the existence of the 
condition and reported a progressive downhill course with a poor outcome in 88% of cases despite 
different treatment strategies.10  They also confirmed that there were no subsequent developments 
of systemic illness with longer follow up of the original group.  Duncan in 1975 coined the term 
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‘idiopathic chondrolysis’ to differentiate the condition from chondrolysis secondary to other 
causes.11  Subsequently the condition was verified with reported cases from around the world.11–21 
Definition 
The presence of stiffness accompanied by the radiographic hallmark of osteopenia and concentric 
reduction of the joint space to less than 3mm can be considered a diagnostic criterion for IC.1,2 
Epidemiology 
The true incidence of IC is unknown.  Fewer than 130 cases have been documented in the literature.1 
Some authors believe that it might be a more common cause of degenerative arthritis in woman.18  
IC affects mostly a unilateral hip, but bilateral cases have been described.22,23  It affects mainly 
adolescents with a mean age of onset of 11 quoted in the literature1, although cases presenting 
shortly after skeletal maturity have been described.24  Girls are affected six times more than boys.2  
Initially it was thought to occur in individuals of African descent only, but subsequently cases have 
been documented from different races across the world.2,24 
Chondrolysis has been described in various other joints, including the knee, ankle, shoulder and 
elbow.25,26  Chondrolysis following arthroscopy were reported in both the knee and shoulder.25   
Aetiology 
The aetiology of the condition remains unknown.  Various theories have been suggested, including 
auto-immune and mechanical theories.  Some authors even suggest IC to be a form of cartilaginous 
dysplasia.27 
Auto-immune theories 
The most widely accepted theory is that the articular cartilage destruction is due to an auto-immune 
response in genetically susceptible individuals.1,2,28  Supporters of this theory have shown 
inflammatory cell infitrates and immunoglobulin deposits in the synovium of the hip joints.12,21,29–31  
Some authors have shown serological abnormalities.2  Ippolito et al noted an absence of the chronic 
degenerative changes seen in osteoarthritis.29  They concluded that idiopathic chondrolysis is a 




Others have proposed various mechanical theories, including a decrease in synovial nutrition,8,32 a 
mechanical insult resulting in release of chondrolytic enzymes2 or an increase in intracapsular 
pressure.6  In SUFE the mechanical theory is supported by the fact that persistent pin or screw 
penetration only in the antero-superior weight-bearing quadrant of the femoral head resulted in 
chondrolysis.33  Hips with transient pin or screw penetration or penetration of the postero-inferior 
quadrant did not develop chondrolysis.  Removal of the penetrating metalware had a 75% chance of 
recovery.  Those patients however who had chondrolysis at presentation were all female of African 
descent with chronic moderate and severe slips, suggesting a genetic and mechanical cause.  The 
results of these hips are poor in the majority of cases,34 which is similar to that of IC reported from 
the same unit.10 
 
Patho-anatomy 
The femoral side of the hip joint is affected primarily according to the literature, with changes 
starting in the weight-bearing area and spreading peripherally.1  Articular cartilage biopsies show 
thinning of the superficial zone, with chondrocyte necrosis.  The basal zone contains some viable 
chondrocytes with disorganised collagen formation.24,29 
 
Biopsies of the synovium show oedematous, hyperplastic synovium.  There are features of a chronic 
inflammation with a perivascular infiltrate of lymphocytes and plasma cells.  Some authors have 
shown immunoglobulin deposits in the synovium of the hip joints12,29–31 although others contradict 
these findings and report immunofluorescent studies for immune complex deposition to be 
normal.35  No gramuloma formation is seen.2 
 
Clinical features 
The typical history is of insidious onset over 2 to 3 months of pain in the groin, anterior thigh or knee 
with progressive stiffness of the hip joint and a limp.1  Examination reveals an antalgic, 
Trendelenburg gait with a typical flexion, abduction and external rotation deformity.  There is 
normally a reduction in movement in all planes and if presentation is delayed patients can present 
with fixed contractures.  Secondary pelvic obliquity, apparent leg length inequality and an increase 
lumbar lordosis can also occur.  There is an absence in systemic symptoms and signs.1 
 
There appears to be two distinct stages in the disease with an initial acute stage with onset of 






Laboratory tests are conducted to exclude other conditions as positive findings preclude the 
diagnosis of IC.  Full blood count, including white cells, blood cultures, inflammatory and auto-
immune markers and Mantoux skin test should all be within normal limits.  C-reactive protein (CRP) 
serum levels are within normal levels, but a slightly elevated erythrocyte sedimentation rate (ESR) of 
up to 30 mm/h has been reported in some cases.36  Markers of auto-immune diseases, including 
rheumatoid factor, antinuclear factor and anti-neutrophil cytoplasmic antibodies are negative.  




Plain radiography is the initial investigation of choice and in the appropriate clinical setting, no 
further radiological investigation is necessary.  Although radiographs can be normal early on in the 
disease process, it is useful to exclude other conditions.  Typical early radiographic changes include 
peri-articular osteopenia, joint space narrowing, small subchondral irregularities and pelvic tilt due 
to the contractures around the hip joint.35 
 
Later in the disease widening of the femoral neck and epiphysis37 and early closing of the femoral 
capital physis is seen,15 as is protrusio.38  Widening of the pubic symphysis has also been described2.  
Features are similar to osteoarthritis, but with preservation of the sphericity of the femoral head .10  
Some authors have postulated that IC and primary acetabular protrusio (PAP) are due to the same 
disease process,38 although these are mostly recognised as distinct entities.  Protrusio acetabuli is 
seen in up to 50% of late radiographs.1 
 
Computed Tomography (CT) 
CT, though superior in depicting anatomical detail and in its sensitivity for detecting subchondral 
bone erosions, its benefit over and above plain radiography is negated by the radiation burden, 
particularly in the vulnerable pediatric setting. 
 
Magnetic resonance imaging (MRI) 
MRI can be used to aid diagnosis where it is unclear.  Changes manifest earlier than on plain film.1   
In addition to the standardized anatomical imaging planes using conventional joint imaging 
protocols, cartilage specific imaging sequences are employed to distinguish the different zones of 
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cartilage (physeal, epiphyseal and articular cartilage) in children.  In addition to the routine 
sequences used for the evaluation of cartilage in adults (intermediate/ proton density with fat 
suppression and T1-weighted spoiled gradient recalled echo with fat suppression) T2-weighted 
sequences that help differentiate the low signal epiphyseal cartilage from the higher signal physeal 
and articular cartilages are also employed.39 
 
Johnson et al divided MRI findings into early and late features.  Early features included focal cartilage 
loss,  marrow oedema in the femoral head and adjacent acetabulum, a small joint effusion without 
significant synovial enhancement, muscle wasting and signs of bone remodelling.35,37,40  Cartilage loss 
is described as mostly centrally from the femoral head.1,37  Late features were more extensive 
marrow oedema and widespread cartilage loss and bone erosions.37  Slight synovial enhancement 
has been described in the early phase,35 but significant synovial enhancement is diagnostic of 
juvenile idiopathic arthritis or chronic infections, like TB. 
 
Other imaging 
Bone scintigraphy, when performed, shows normal flow and bone uptake but diffuse peri-articular 
uptake suggestive of a diffuse inflammatory process.18 
 
Differential diagnosis 
IC is a diagnosis of exclusion and the differential is wide.  Septic arthritis of the hip must be excluded.  
In South Africa where tuberculosis (TB) is prevalent, the main differential is atrophic-type TB of the 
hip.41  In TB femoral and acetabular erosions are seen on plain radiographs.42 
 
Chondrolysis secondary to other causes must also be excluded.  A variety of other conditions can 
present in a similar manner, namely SUFE (with or without chondrolysis), Perthes’ disease, trauma, 
PAP, juvenile idiopathic arthritis (although the hip is affected very rarely in the pauciarticular form) 
and pigmented villonodular synovitis.1  Some authors even suggest IC and juvenile idiopathic 
arthritis (JIA) are the same entity and should be treated as such.21 
 
Natural history 
The natural history of idiopathic chondrolysis is unpredictable.  Originally it was thought to follow a 
relentless progressive course towards malpositioned fibrous ankylosis.10  Since then a variety of 
outcomes from spontaneous resolution to painful ankylosis have been described.1,9,10  Several 
authors describe spontaneous resolution of the condition over time.15,16,43  Some authors even 
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describe restoration of the joint space with up to 2mm over time.1  It is said that an acceptable 
clinical outcome can be achieved in 50 to 60% of cases with conservative treatment.1 
 
There appears to be two distinct stages in the disease.   An initial acute phase is characterised by an 
inflammatory response with cartilage destruction and worsening hip pain and decreased hip motion 
over up to 18 months.1  This is followed with a chronic phase that is less predictable and lasts three 
to five years.2  There appears to be three distinct clinical outcomes with half the patients showing 
clinical improvement over time.  Even complete resolution is reported in extreme cases.  The second 
group develops a stiff hip that limits function, but is pain free.  The third group regresses to a painful, 
malpositioned ankylosis.  Currently there are no known indicators to predict the individual outcome 
of the chronic phase.1 
 
Treatment options 
Initially early, aggressive operative treatment of IC was practised, including soft tissue releases, 
corrective osteotomies, arthrodesis and arthroplasty.1  Better understanding of the natural history 
led to a more conservative approach.  Non-operative treatment aims at relieving pain, maintaining 
range of motion and offloading the hip joint.  There is no general consensus on how this is best 
achieved.   A treatment protocol of NSAIDs, prolonged protected weightbearing, aggressive 
physiotherapy and periodic traction have shown clinical improvement in 50% to 60% of cases.15,16  
Continuous or intermittent traction may also improve the condition, although this is needed for up 
to 3 months and not without associated morbidity.1  CPM has also been reported to have a positive 
effect.3  The possible auto-immune cause suggests that the powerful anti-inflammatory properties of 
the tumour necrosis factor-blockers might be useful.  There is a single case study of successful 
treatment with etanercept.44  
 
Operative treatment is reserved for patients who have failed prolonged non-operative treatment.  A 
wide variety of surgical interventions have been described with variable success.  Early surgical 
interventions include soft-tissue releases to correct hip deformity, capsulectomy and articulated 
hinged distraction.  Aldegheri et al reported clinical improvement despite radiological deterioration 
in cases of articulated distraction for chondrolysis secondary to SUFE.45  Articulated distraction has 
also been described for the adolescent arthritic hip due to other causes with encouraging results.46  
Salvage procedures include excision arthroplasty, arthroplasty and arthrodesis.  Some authors 




Subtotal capsulectomy with soft tissue releases 
Roy and Crawford6 in 1988 described a subtotal capsulectomy with soft tissue releases and 
aggressive rehabilitation in three cases.  They performed a subtotal (270°) circumferential 
capsulectomy excising a 1 cm strip of capsule, sparing the posterior 90° to preserve blood supply to 
the femoral head, while taking care not to injure the labrum.  Concomitant soft-tissue releases were 
performed as necessary to address joint contractures.  The origin of the sartorius muscle and the 
straight head of the rectus femoris muscle were released.  A psoas tenotomy was performed at the 
pelvic brim and the tensor fascia lata was released proximally to improve the abduction contracture.  
This was followed by aggressive rehabilitation, including the use of CPM.6  Although intra-articular 
pressure was never measured, they postulated that an increase in intra-articular pressure was 
relieved.  One case received another manipulation under anaesthesia.  They described good results 
at an average of more than 3 year follow up with all patients being symptom free with improvement 
in range of motion.  They also reported restoration of the joint space on radiographs in all cases and 
therefor justified aggressive early surgical intervention.6  Laor and Crawford35 later reported on a 
series of seven hips in six patients that all underwent the same procedure.  Only three cases showed 
clinical and radiological resolution following the procedure with another showing moderate joint 
space narrowing.  The remaining three hips developed severe ongoing loss of joint space resulting in 
total hip replacements in two hips at a young age. 
 
Other authors reported clinical and radiological progression of the disease following similar surgical 
procedures38 and early clinical improvement with radiological deterioration and no long term 
benefit.7  Korula et al47 reported on the largest series of surgically managed IC cases with an average 
follow up of 23.4 months.  They performed a similar subtotal capsulectomy and found a small, but 
statistically significant improvement in hip range of motion.  The pre-operative arc was improved 
slightly and was brought into a more functional range postoperatively. 
 
The current recommendations from the literature are to control inflammation and ROM in the acute 
stage.  This is achieved through the use of NSAIDs, physiotherapy, protected weightbearing, CPM 





Areas for further research 
Idiopathic chondrolysis remains a challenge to physicians in both the aetiology and treatment.  Basic 
science research can hopefully shed the light on the exact aetiology and pathogenesis of the 
cartilage degradation. 
Various alternative treatment modalities should be further researched.  As previously mentioned the 
possible auto-immune cause suggests that the powerful anti-inflammatory properties of the tumour 
necrosis factor-blockers might be useful.  There is a single case study of successful treatment with 
etanercept and this needs to be further researched.44  Salter in 1980 demonstrated the effect of 
CPM on healing of full thickness defects in articular cartilage.48 In theory it should be possible to 
address acetabular cartilage loss with chondrogenesis through metaplasia by drilling subchondral 
bone and CPM. 
The rarity of the condition makes research difficult as even large referral centres might only see up 
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Idiopathic chondrolysis (IC) of the hip is a rare, crippling condition affecting mainly adolescent 
females.  Cartilage necrosis results in a stiff, painful hip which in the majority of cases have a poor 
outcome.  The aetiology still remains unknown and the treatment controversial and relatively 
unsuccessful.  Subtotal capsulectomy with soft tissue releases has been reported to give good 
results. 
Methods 
Five female adolescents with IC of the hip were reviewed in order to shed light on the aetiology, 
delineate the role of magnetic resonance imaging (MRI) pre- and post-operatively and assess the 
outcome of a subtotal capsulectomy.  The surgical technique was performed as originally described 
with concomitant releases of the deformities.  Samples of synovium and cartilage were sent for 
histology and culture (including tuberculosis culture).  Pre- and post-operatively the patients were 
evaluated regarding pain, deformity and range of motion (ROM).  Follow up radiographs and MRI 
scans were performed and compared to pre-operative imaging. 
Results 
Blood tests for auto-immune markers were negative in all cases.  MRI pre-operatively showed 
erosions and mainly destruction of the superomedial acetabular cartilage.  Histology of the synovium 
showed chronic, non-specific inflammation with a plasma cell infiltrate, suggesting an auto-immune 
cause.  Histology of the cartilage confirmed cartilage necrosis.  At follow up (mean 11 months) four 
of the five patients were pain free, but all five had an improvement in pain.  There was an 
improvement in deformity and range of motion in four cases.  Post-operative imaging (radiographs 
and MRI) at a mean of eight months, however, showed deterioration of the pathology with increase 
of the erosions, joint space narrowing and cartilage destruction. 
Conclusions 
We conclude that the aetiology is most likely an auto-immune process.  MRI was helpful in 
delineating the cartilage pathology.  A subtotal capsulectomy offers early post-operative clinical 
relief.  Radiological deterioration however suggests that the surgery does not prevent deterioration 
of pathology. 
Level of Evidence 
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Level IV:  Case series 
Key words:  Idiopathic chondrolysis, hip, subtotal capsulectomy 
28 
Introduction 
Idiopathic chondrolysis of the hip is a very rare disorder that occurs mostly in adolescents with fewer 
than 130 cases documented1.  It is characterized by rapid cartilage necrosis of the hip joint, not 
associated with trauma, slipped upper femoral epiphysis (SUFE), infection or other demonstrable 
causes.2  Patients present with insidious onset of pain, a limp and a typical flexion, abduction and 
external rotation deformity of the hip joint. 
It was first described in 9 adolescents by Jones in 1971. The disease did not conform to other known 
conditions justifying the recognition of a distinct clinical entity.3  In 1982 Sparks and Dall from the 
same unit reported on the original series and a further 9 patients.  They confirmed the existence of 
the condition and reported a progressive downhill course with a poor outcome in 88% of cases 
despite different treatment strategies.4  Subsequently the condition was verified with reported cases 
from around the world.5–15 
The aetiology remains unknown.  Theories include an auto-immune response in genetically 
susceptible individuals5,16 and mechanical theories such as a decrease in synovial nutition17, a 
mechanical insult with release of chondrolytic enzymes2 and an increase in intracapsular pressure.18 
The presence of stiffness accompanied by radiographic osteopenia and concentric reduction of the 
joint space to less than 3mm can be considered a diagnostic criterion for IC.1,2  In our setting the 
main differential diagnosis is atrophic-type tuberculosis of the hip.19,20 
The natural history of idiopathic chondrolysis is unpredictable.  A variety of outcomes from 
spontaneous resolution to painful ankylosis have been described.1,3,4  There appears to be two 
stages in the disease with an initial acute stage with onset of symptoms caused by an inflammatory 
response.  This is followed by a chronic phase with an unpredictable course.1,2 
Various treatment strategies have been advocated.  Non-operative treatment with non-steriodal 
anti-inflammatory drugs (NSAIDs), non-weight bearing and physiotherapy, including continuous 
passive motion (CPM), are used.21–23  In 1988 Roy and Crawford reported on a subtotal capsulectomy 
with soft tissue releases followed by aggressive rehabilitation.18  Three cases were treated with good 
results.  Subsequent studies reported indifferent results with the same technique.24   
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The purpose of our study was to try and shed light on the aetiology, to delineate the role of MRI and 
to assess the outcome of subtotal capsulectomy. 
 
 
Materials and Methods 
Five adolescent female patients with a mean age of 11 years (range 10 to 12 years) treated from 
January 2011 to August 2012 were reviewed.  During this period no patient was treated successfully 
non-operatively.  The median duration of symptoms was 2 months (range 2-24 months).  We 
performed a retrospective review of prospectively collected data on these patients.  No patients 
were excluded from analysis. 
 
Pre-operatively the patients were assessed clinically.  Blood work-up included full blood count, 
erythrocyte sedimentation rate (ESR), rheumatoid factor, antinuclear factor and anti-neutrophil 
cytoplasmic antibodies.  A chest radiograph and a Mantoux skin test were done.  Pelvic radiograph, 
computed tomography (CT) and MRI scans of the hip were done.  In addition to the standardized 
MRI anatomical imaging planes using conventional joint imaging protocols, cartilage specific imaging 
sequences were employed to distinguish the different zones of cartilage (physeal, epiphyseal and 
articular cartilage) in children.  In addition to the routine sequences used for the evaluation of 
cartilage in adults (intermediate / proton density with fat suppression and T1-weighted spoiled 
gradient recalled echo with fat suppression) we also employed T2-weighted sequences that help 
differentiate the low signal epiphyseal cartilage from the higher signal physeal and articular 
cartilages.25 
 
All patients underwent an extensive course of non-operative management that included NSAIDs, 
physiotherapy and CPM.  All five patients underwent subtotal capsulectomy with soft tissue 
releases.  The surgical technique was as described by Roy and Crawford.18  A 1 cm strip of hip 
capsule was excised for an arc of 270°.  The posterior 90°was spared to preserve the blood supply to 
the femoral head.  A psoas tenotomy at the pelvic brim and a release of the straight head of rectus 
femoris were done to release the flexion contracture of the hip.  The tensor fascia lata was released 
to improve the abduction deformity.  Synovial biopsies were sent for histology and culture (including 




Postoperatively the patients were initially treated in bilateral skin traction.  After 7 to 10 days 
physiotherapy, including CPM was initiated.  Patients received NSAID’s for 6 weeks. 
At a mean follow up of 11 months (range 9 to 16 months) the patients were assessed for pain and 
ROM.  Follow up radiographs and MRI scans were done at a mean of 8 months to assess the disease 
progression. 
Results 
All the patients presented with pain and stiffness of the affected hip.  Examination revealed an 
antalgic, Trendelenburg gait and a painful, stiff hip with a flexion, abduction and external rotation 
deformity in all cases (Table I).  All blood tests including the auto-immune markers were normal.  
Chest radiographs were clear and Mantoux skin tests negative in all cases. 
Initial pelvic radiographs revealed osteopenia, concentric joint space narrowing (less than 3mm) and 
the deformity was visible in all cases (Figure 1).  In one case subchondral erosions were visible on 
plain radiograph.  Two cases fulfilled radiological criteria for protrusio bilaterally.  CT confirmed 
osteopenia and joint space narrowing in all cases, and subchondral erosions were seen in three 
(Figure 2).  MRI scan at presentation was performed in four patients (it was not performed in one 
case due to non-availability of the scanner).  In all four cases where an initial MRI was performed 
joint space narrowing and marrow oedema was seen (Figure 3-A).  Subchondral erosions were seen 
in three out of four cases (Figure 3-B).  The cartilage loss and erosions were mostly acetabular and 
mainly in the superomedial weight bearing area of the acetabulum (Figure 3-D).  Slight synovial 
enhancement was seen in one case. 
Non-operative treatment failed in all cases.  Histological examination of the synovium showed signs 
of mild, non-specific chronic inflammation with a perivascular infiltrate of lymphocytes and plasma 
cells in all cases.  There was no evidence of granulomatous inflammation (Figure 4-A).  
Macroscopically, the cartilage appeared lustreless.  Microscopically, there was an outer layer of 
fibroblastic tissue with an adjacent layer of degenerate chondrocytes.  There were viable 
chondrocytes at the base (Figure 4-B).  Microbiological culture was negative in all cases, including 
extended TB culture. 
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At last follow up all patients subjectively felt that their pain improved.  Four patients felt that their 
hips were pain free.  The gait improved in four out of the five cases.  The deformity was improved in 
four cases.  In one case the patient’s hip was still painful and there was no improvement in the 
deformity (Table I). 
 
Post-operative radiographs showed deterioration of the joint space narrowing in four of the five 
cases.  On MRI subchondral erosions were now visible in all five hips and cartilage destruction was 




Idiopathic chondrolysis occurs mostly unilateral, although bilateral cases have been described.26,27  It 
affects adolescents with a predominance among girls, but male cases and cases presenting shortly 
after skeletal maturity have been described.28  Initially it was thought to occur in individuals of 
African descent only, but subsequently cases have been documented from different races across the 
world.2,28  Literature is limited to case studies and small case series. 
 
Aetiology  
The most widely accepted theory is that the articular cartilage destruction is due to an auto-immune 
response in genetically susceptible individuals.1,2,29  Supporters of this theory have shown 
inflammatory cell infiltrates and immunoglobulin deposits in the synovium of the hip joints.5,16,30,31  
Some authors have shown serological abnormalities.2  In our series auto-immune markers were all 
negative.  A slightly elevated ESR of less than 30mm/h has been reported.32  The synovial 
inflammatory infiltrate, especially plasma cells, supports the theory of an auto-immune disease.  This 
suggests that the powerful anti-inflammatory properties of the tumour necrosis factor-blockers 
might be useful.  There is a single case study of successful treatment with etanercept.33 
  
Mechanical theories are a decrease in synovial nutrition,17,34 a mechanical insult with release of 
chondrolytic enzymes2 or an increase in intracapsular pressure which is supposedly released by 
subtotal capsulectomy.18  In SUFE the mechanical theory is supported by the fact that persistent pin 
or screw penetration in the antero-superior weight-bearing quadrant of the femoral head resulted in 
chondrolysis.35,36  Hips with transient penetration or penetration of the postero-inferior quadrant did 
not develop chondrolysis.  Removal of the penetrating metal ware had a 75% chance of recovery.  
Those patients however, who had chondrolysis at presentation before surgery, were all female of 
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African descent with chronic moderate or severe slips, suggesting a genetic and mechanical cause. 
The results of these hips are poor in the majority of cases,36 which is similar to that of IC reported 
from the same unit.4 
Some authors suggest IC to be a form of cartilaginous dysplasia.37 
Ippolito et al in an ultrastructural study of the articular cartilage in IC found no resemblance to the 
chronic degenerative changes seen in osteoarthritis.  They concluded IC to be a pathological process 
which, unlike osteoarthritis, runs its course very quickly.30 
Imaging 
Plain radiography is the initial investigation of choice and in the appropriate clinical setting, no 
further radiological investigation is necessary.  Radiographs are frequently normal early on in the 
disease process.1  Subsequent findings reveal joint space narrowing, juxta-articular osteopenia and 
small subchondral irregularities together with remodelling of the femoral neck and epiphysis.38  
Premature closure of the femoral capital physis9 and protrusio acetabuli39 is also documented.  Late 
manifestations of the disease reflect the secondary degenerative changes of osteoarthritis.4 
Our investigation demonstrated the typical plain radiographic findings of joint space narrowing, 
juxta-articular osteopenia and joint deformity.  In addition, two cases revealed bilateral protrusio 
acetabuli according to radiographic criteria.  Some authors have implicated the same disease process 
in IC and primary acetabular protrusio despite their distinct natures.39  Only one case in our series 
demonstrated subchondral erosions on the initial radiograph. 
CT, though superior in depicting anatomical detail and in its sensitivity for detecting subchondral 
bone erosions (three out of five cases at presentation), its benefit over and above plain radiography 
is negated by the radiation burden, particularly in the vulnerable pediatric setting.  Hence this has 
subsequently been excluded from our diagnostic workup. 
We found MRI useful in aiding diagnosis in difficult cases as well as assessing progression of the 
disease.  MRI findings are divided into early and late features.  Early features included focal cartilage 
loss, bone marrow oedema, a small joint effusion without significant synovial enhancement, muscle 





Our case series demonstrated similar features with the notable exception of early articular cartilage 
destruction afflicting the acetabular cartilage (superomedial weight-bearing areas) more than the 
femoral head cartilage as suggested by earlier reports.38,40  Synovial enhancement was documented 
in one of four of the initial MRI studies in our series.  Slight synovial enhancement has been 
described in the early phase of IC.40  Significant synovial enhancement is however more suggestive of 
juvenile idiopathic arthritis (JIA) or chronic infections including TB.  MRI is therefore useful in both 
the diagnostic workup and for the follow-up of disease progression in IC and is routinely employed in 
suspected cases in our practice. 
 
The only realistic differential diagnosis to be entertained in the local clinical scenario is that of 
atrophic-type tuberculosis of the hip.  A study by Reardon et al compared radiographs of 8 patients 
with IC and 9 with atrophic tuberculosis.  Plain radiographs of the TB hips showed peri-articular 
erosions which were absent in IC.20  In the current study three hips had subchondral erosions at 
presentation on CT and MRI, mainly superomedially in the acetabulum.  Monoarthritis of the hip in 
JIA, is invoked as a likely mimic in the literature1, but has never been documented at our institution. 
 
Outcome 
Several authors describe spontaneous resolution of the condition over time.9,10,42  This is not our 
experience, with none of our patients responding to prolonged non-operative management. 
 
An interesting finding was that the ROM improved under general anaesthetic prior to surgery in all 
cases.  This confirms that muscle spasm contributes to the deformity as shown by previous authors.3 
 
Roy and Crawford in 1988 described a subtotal capsulectomy with soft tissue releases and aggressive 
rehabilitation in three cases.18  Although intracapsular pressure was never measured they felt it 
relieved increased intracapsular pressure.  They described good results with improvement in pain 
and range of motion in all cases, which was reproduced by some authors.13  They also reported 
restoration of the joint space on radiographs.18  Other authors however reported clinical and 
radiological progression of the disease following similar surgical procedures39,40,43 and early clinical 
improvement with radiological deterioration and no long term benefit.24  In all our cases the pain 
was improved following surgery, with four out of five cases pain free.  The deformity was also 
improved in four cases, with a slight improvement of the ROM of the hip.  In all five cases though 
there was radiological progression.  On plain radiograph there was deterioration of the joint space 
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narrowing and more subchondral erosions were visible.  Follow up MRI revealed more severe 
cartilage destruction in all cases.  From these findings we conclude that although the subtotal 
capsulectomy offers some relief of pain and deformity, it does not alter the progression of the 
disease.  It does however allow the hip to stiffen up in a more favourable position. 
Other treatment modalities have been described.  Aldegheri et al reported clinical improvement 
despite radiological deterioration in cases of articulated distraction for chondrolysis secondary to 
SUFE.44  Articulated distraction has also been described for the adolescent arthritic hip due to other 
causes with encouraging results.45  Our experience with this technique in chondrolysis in SUFE was 
disappointing.  Salter et al in 1980 demonstrated the effect of CPM on healing of full thickness 
defects in articular cartilage.46 In theory it should be possible to address acetabular cartilage loss 
with chondrogenesis through metaplasia by drilling subchondral bone and CPM.  The viable 
chondrocytes shown in the basal cartilage at histology may benefit from this treatment.  The use of 
biological agents like etanercept is also a possibility as discussed earlier.33  More research is needed 
on these novel treatments. 
Limitations 
The main limitation of our study is the retrospective nature as well as the lack of a clinical scoring 
system to evaluate outcome.  We also had a small series, but due to the extreme rarity of the 
condition most studies on the topic are limited to small case series. 
Conclusions 
We conclude that the aetiology is most likely an auto-immune process.  MRI was helpful in 
delineating the cartilage pathology, which was mainly on the acetabular side.  A subtotal 
capsulectomy offers early post-operative clinical relief.  Radiological deterioration suggests that the 
surgery does not prevent progression of the pathology. 
35 
References 
1. Segaren N, Abdul-Jabar HB, Segaren N, Hashemi-Nejad A. Idiopathic chondrolysis of the hip:
presentation, natural history and treatment options. J Pediatr Orthop B. 2014;23(2):112–6.
2. Dobbs MB, Morcuende JA. Other Conditions of the Hip. In: Morrissy RT, Weinstein SL, eds.
Lovell&Winter’s Pediatric Orthopaedics. 6th ed. Philadelphia: Lippincot Williams&Wilkens;
2006:1147–1152.
3. Jones BS. Adolescent chondrolysis of the hip joint. South African Med J. 1971;(February):196–
202.
4. Sparks LT, Dall G. Idiopathic chondrolysis of the hip joint in adolescents. South African Med J.
1982;61(June):883–886.
5. Moule NJ, Golding JSR. Idiopathic chondrolysis of the hip. Clin Radiol. 1974;25(2):247–251.
doi:10.1016/S0009-9260(74)80062-0.
6. Wenger DR, Mickelson MR, Ponseti I V. Idiopathic chondrolysis of the hip. Report of two
cases. J Bone Joint Surg Am. 1975;57(2):268–271.
7. Duncan JW. The Bizarre Stiff Hip. JAMA. 1975;231(4):382.
8. Smith EJ, Ninin DT, Keays AC. Idiopathic chondrolysis of the hip. A case report. South African
Med J. 1983;63(3):88–90.
9. Bleck EE. Idiopathic chondrolysis of the hip. J Bone Joint Surg Am. 1983;65(9):1266–1275.
10. Daluga DJ, Millar EA. Idiopathic chondrolysis of the hip. J Pediatr Orthop. 1989;9(4):405–411.
11. Donnan L, Einoder B. Idiopathic chondrolysis of the hip. ANZ J Surg. 1996;66(8):569–571.
12. Kozlowski K, Scougall J. Idiopathic chondrolysis — diagnostic difficulties. Pediatr Radiol.
1984;14(5):314–317.
13. Nutthapong Wongwiwat M. Idiopathic Chondrolysis of the Hip: A Case Report and Review of
the Literature. Thai J Orthop Surg. 2006;31(2):94 – 99.
14. Sivanantham M, Kutty MK. Idiopathic chondrolysis of the hip: case report with a review of the
literature. ANZ J Surg. 1977;47(2):229–231.
15. Van der Hoeven H, Keessen W, Kuis W. Idiopathic chondrolysis of the hip: A distinct clinical
entity? Acta Orthop Scand. 1989;60(6):661–663.
16. Eisenstein A, Rothschild S. Biochemical abnormalities in patients with slipped capital femoral
epiphysis and chondrolysis. J Bone Joint Surg Am. 1976;58(4):459–467.
17. Waldenstrom H. On necrosis of the joint by epiphysiolysis capitis femoris. Acta Chir Scand.
1930;67:936–946.
18. Roy DR, Crawford AH. Idiopathic chondrolysis of the hip: management by subtotal
capsulectomy and aggressive rehabilitation. J Pediatr Orthop. 1988;8:203–207.
36 
 
19.  Campbell JAB, Hoffman EB. Tuberculosis of the hip in children. J Bone Joint Surg Br. 
1995;77(2):319–326. 
20.  Reardon TC, Holm H, Solomon R, Sparks LT, Hoffmann EB. Idiopathic chondrolysis versus 
atrophic tuberculosis of the hip in children: the problem of differential diagnosis. J Bone Jt 
Surgery, Br Vol. 2003;85-B(SUPP II):148. 
21.  Hughes AW. Idiopathic chondrolysis of the hip: a case report and review of the literature. Ann 
Rheum Dis. 1985;44(4):268–272. 
22.  Bilski P, Snela S. Difficulties in treating chondrolysis and avascular necrosis of the hip in 
adolescent patients. Ortop Traumatol Rehabil. 2006;8(1):34–40. 
23.  François J, Mulier M. Idiopathic chondrolysis of the hip: A case report. Acta Orthop Belg. 
2007;73(5):653–657. 
24.  Del Gouz Garcia A, Fernandez PL, Gonzalez MPC, Garcia AC, Gonzalez LR, Jimenez JP. 
Idiopathic Chondrolysis of the Hip: Long-Term Evolution. J Pediatr Orthop. 1999;19(4):449–
454. 
25.  Jaramillo D. Cartilage imaging. Pediatr Radiol. 2008;38 Suppl 2:256–258. 
26.  Rachinsky I, Boguslavsky L, Cohen E, Hertzanu Y, Lantsberg S. Bilateral Idiopathic Chondrolysis 
of the Hip. Clin Nucl Med. 2000;25(12):1007–1009. 
27.  Rowe LJ, Ho EK. Idiopathic chondrolysis of the hip. Skeletal Radiol. 1996;25(2):178–182. 
28.  Ippolito E, Ricciardi-Pollini PT. Chondrolysis of the hip (idiopathic and secondary forms). Ital J 
Orthop Traumatol. 1981;7(3):335–344. 
29.  Herman JH, Herzig EB, Crissman JD, Dennis M V, Hess E V. Idiopathic chondrolysis--an 
immunopathologic study. J Rheumatol. 1980;7(5):694–705. 
30.  Ippolito E, Bellocci M, Santori FS, Ghera S. Idiopathic chondrolysis of the hip: an 
ultrastructural study of the articular cartilage of the femoral head. Orthopedics. 
1986;9(10):1383–1387. 
31.  Morrissy RT, Kalderon AE, Gerdes MH. Synovial immunofluorescence in patients with slipped 
capital femoral epiphysis. J Pediatr Orthop. 1981;1(1):55–60. 
32.  Duncan J, Nasca R, Schrantz J. Idiopathic chondrolysis of the hip. J Bone Joint Surg Am. 
1979;61(7):1024–1028. 
33.  Appleyard D V, Schiller JR, Eberson CP, Ehrlich MG. Idiopathic Chondrolysis Treated With 
Etanercept. Orthopedics. 2009;32(3):214. 
34.  Cruess RL. The Pathology of Acute Necrosis of Cartilage in Slipping of the Capital Femoral 




35.  Vrettos BC, Hoffman EB. Chondrolysis in slipped upper femoral epiphysis. Long-term study of 
the aetiology and natural history. J Bone Joint Surg Br. 1993;75(6):956–961. 
36.  Nortje MB, Dix-Peek S, Vrettos BC, Hoffman EB. Avascular necrosis and chondrolysis in 
slipped upper femoral epiphysis: A comparative study between multiple pin fixation with or 
without osteotomy and single screw fixation. South African Orthop J. 2009;(Summer):30–37. 
37.  Stanescu R, Stanescu V, Maroteaux P, Peyron J. Constitutional articular cartilage dysplasia 
with accumulation of complex lipids in chondrocytes and precocious arthrosis. Arthritis 
Rheum. 1981;24(7):965–968. 
38.  Johnson K, Haigh SF, Ehtisham S, Ryder C, Gardner-Medwin J. Childhood idiopathic 
chondrolysis of the hip: MRI features. Pediatr Radiol. 2003;33(3):194–199. 
39.  Sherlock DA. Acute idiopathic chondrolysis and primary acetabular protrusio may be the 
same disease. J Bone Joint Surg Br. 1995;77(2):392–395. 
40.  Laor T, Crawford AH. Idiopathic chondrolysis of the hip in children: early MRI findings. Am J 
Roentgenol. 2009;192(2):526–531. 
41.  Mounach A, Nouijai A, Ghozlani I, et al. Idiopathic chondrolysis of the hip. Joint, bone, spine. 
2007;74(6):656–658. 
42.  Lejman T, Sulko J. Idiopathic chondrolysis of the hip. Chir Narzadow Ruchu Ortop Pol. 
2005;70(2):97–100. 
43.  Korula RJ, Jebaraj I, David KS. Idiopathic chondrolysis of the hip: medium- to long-term 
results. ANZ J Surg. 2005;75(9):750–753. 
44.  Aldegheri R, Trivella G, Saleh M. Articulated distraction of the hip conservative surgery for 
arthritis in young patients. Clin Orthop Relat Res. 1994;301:94–101. 
45.  Thacker MM, Feldman DS, Madan SS, Straight JJ, Scher DM. Hinged distraction of the 
adolescent arthritic hip. J Pediatr Orthop. 2005;25(2):178–182. 
46.  Salter R, Simmonds D, Malcolm B, Rumble E, MacMichael D, Clements N. The biological effect 
of continuous passive motion on the healing of full-thickness defects in articular cartilage. An 










Table 1:  Pre- and latest follow-up deformity and ROM 
 Mean value (range) 
 Pre-operative   Follow-up 
Deformity   
 Fixed-flexion deformity 31° (20°-45°) 26° (20°-30°) 
 Abduction deformity 22° (10°-30°) 13° (0°-30°) 
 External rotation deformity 20° (10°-30°) 8° (0°-30°) 
Range of motion   








Figure 1:  A-P radiograph of the pelvis of a 11-year-old girl with IC of the right hip showing typical 
findings of osteopenia, joint space narrowing (JSN), closure of the femoral capital physis and flexion, 
abduction and external rotation deformities. 
  
 








Figure 3:  Presentative images from our series to demonstrate typical MRI features 
 
A)  Coronal T2-weighted sequence showing JSN and oedema of the right hip. 
 
 
B)  Coronal T2-weighted sequence with fat suppression showing JSN and subchondral erosion on the 






C)  Coronal gradient echo sequence showing normal acetabular and femoral cartilage. 
 
 







Figure 4:  Histological findings 
 
A)  Synovial biopsy showing a perivascular infiltrate of lymphocytes and plasma cells. 
 
 
B) Cartilage biopsy showing an outer layer of fibroblastic tissue with an adjacent layer of degenerate 
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of Lippincott Williams & Wilkins. Each person listed as an author is expected to have participated in 
the study to a significant extent. Although the editors and referees make every effort to ensure the 
validity of published manuscripts, the final responsibility rests with the authors, not with the 
Journal, its editors, or the publisher. All manuscripts must be submitted on-line through the 
Journal's Web site at http://jpo.edmgr.com/. See submission instructions under "On-line 
manuscript submission." 
 
Patient Anonymity and Informed Consent  
It is the author's responsibility to ensure that a patient's anonymity be carefully protected and to 
verify that any experimental investigation with human subjects reported in the manuscript was 
performed with informed consent and following all the guidelines for experimental investigation 
with human subjects required by the institution(s) with which all the authors are affiliated. Authors 
should remove patients' names and other identifying information from figures. If any identifying 
details appear in text, tables, and/or figures, the author must provide proof of informed consent 
obtained from the patient (i.e., a signed permissions form). Photographs with bars placed over 
eyes of patients should NOT be used in publication. If they are used, permission from the 
patient is required.  
Copyright 
All authors must sign a copy of the Journal's "Authorship Responsibility, Financial Disclosure, and 
Copyright Transfer" form and submit it at the time of manuscript submission to Julie Chase at 
(fax) 215-827-5586.  
Open access  
LWW’s hybrid open access option is offered to authors whose articles have been accepted for 
publication. With this choice, articles are made freely available online immediately upon 
publication. Authors may take advantage of the open access option at the point of acceptance to 




are subject to the journal’s standard peer-review process and will be accepted or rejected based 
on their own merit.  
Authors of accepted peer-reviewed articles have the choice to pay a fee to allow perpetual 
unrestricted online access to their published article to readers globally, immediately upon 
publication. The article processing charge for Journal of Pediatric Orthopaedics is $2,000. The 
article processing charge for authors funded by the Research Councils UK (RCUK) is $2,580. The 
publication fee is charged on acceptance of the article and should be paid within 30 days by credit 
card by the author, funding agency or institution. Payment must be received in full for the article 
to be published open access. Any additional standard publication charges, such as for color 
images, will also apply.  
 Authors retain copyright 
Authors retain their copyright for all articles they opt to publish open access. Authors grant 
LWW a license to publish the article and identify itself as the original publisher.  
 Creative Commons license 
Articles opting for open access will be freely available to read, download and share from 
the time of publication. Articles are published under the terms of the Creative Commons 
License Attribution-NonCommerical No Derivative 3.0 which allows readers to disseminate 
and reuse the article, as well as share and reuse of the scientific material. It does not 
permit commercial exploitation or the creation of derivative works without specific 
permission. To view a copy of this license visit: http://creativecommons.org/licenses/by-
nc-nd/3.0.  
 Compliance with NIH, RCUK, Wellcome Trust and other research funding agency 
accessibility requirements 
A number of research funding agencies now require or request authors to submit the post-
print (the article after peer review and acceptance but not the final published article) to a 
repository that is accessible online by all without charge. As a service to our authors, LWW 
identifies to the National Library of Medicine (NLM) articles that require deposit and 
transmits the post-print of an article based on research funded in whole or in part by the 
National Institutes of Health, Howard Hughes Medical Institute, or other funding agencies 
to PubMed Central. The revised Copyright Transfer Agreement provides the mechanism. 
LWW ensures that authors can fully comply with the public access requirements of major 
funding bodies worldwide. Additionally, all authors who choose the open access option will 
have their final published article deposited into PubMed Central.  
 
RCUK and Wellcome funded authors can choose to publish their paper as open access with 
the payment of an article process charge (gold route), or opt for their accepted manuscript 
to be deposited (green route) into PMC with an embargo.  
 
With both the gold and green open access options, the author will continue to sign the 
Copyright Transfer Agreement (CTA) as it provides the mechanism for LWW to ensure that 
the author is fully compliant with the requirements. After signature of the CTA, the author 
will then sign a License to Publish where they will then own the copyright. Those authors 
who wish to publish their article via the gold route will be able to publish under the terms 
of the Attribution 3.0 (CCBY) License. To view of a copy of this license visit: 




article via the green route will be able to publish under the rights of the Attribution Non-
commercial 3.0 (CCBY NC) license (http://creativecommons.org/licenses/by-nc/2.0/).  
 
It is the responsibility of the author to inform the Editorial Office and/or LWW that they 
have RCUK funding. LWW will not be held responsible for retroactive deposits to PMC if the 
author has not completed the proper forms.  
FAQ for open access 
http://links.lww.com/LWW-ES/A48  
Conflicts of interest  
For the timespan covering the work being presented (study planning, conduct, analysis, and 
dissemination to date), authors are required to disclose all possible conflicts of interest in the 
manuscript, including financial, consultant, institutional and other relationships that might lead to 
bias or a conflict of interest. If there is no conflict of interest, this should also be explicitly stated 
as none declared. All sources of funding should be acknowledged in the manuscript. All relevant 
conflicts of interest and sources of funding should be included on the title page of the manuscript 
with the heading “Conflicts of Interest and Source of Funding:”. For example:  
Conflicts of Interest and Source of Funding: A has received honoraria from Company Z. B is 
currently receiving a grant (#12345) from Organization Y, and is on the speaker’s bureau for 
Organization X – the CME organizers for Company A. For the remaining authors none were 
declared.  
In addition, each author must complete and submit the Journal’s copyright transfer agreement, 
which includes a section on the disclosure of potential conflicts of interest based on the 
recommendations of the International Committee of Medical Journal Editors, “Uniform 
Requirements for Manuscripts Submitted to Biomedical Journals” (www.icmje.org/update.html). 
The form is readily available on the manuscript submission page and can be completed and 
submitted electronically. Please note that authors may sign the copyright transfer agreement form 
electronically. For additional information about electronically signing this form, go to 
http://links.lww.com/ZUAT/A106.  
Permissions  
Authors must submit written permission from the copyright owner (usually the publisher) to use 
direct quotations, tables, or illustrations that have appeared in copyrighted form elsewhere, along 
with complete details about the source. Any permissions fees that might be required by the 
copyright owner are the responsibility of the authors requesting use of the borrowed material, not 
the responsibility of Lippincott Williams & Wilkins.  
Original Articles 
Articles should not exceed 2,500 words.  
Case Reports 
All Case Reports must have a Structured Abstract and will be published online only. The abstract 
will appear in the hard copy of the Journal, and the readers will be directed to the Journal’s Web 
site to view the paper in its entirety. All papers published online only will be completely referenced 




On the Other Hand 
The Journal accepts submissions for its feature column, "On the Other Hand." Submit ideas, hints, 
suggestions and tips in the form of one- to two-thought concepts, 500 - 600 words in length, 
accompanied by illustrations and a bibliography when appropriate. The Journal also publishes 
reader response letters about items that have appeared in the "On the Other Hand" column.  
Letters to the Editor 
The Journal welcomes letters about articles that have appeared in recent issues. Letters are 
forwarded to the author of the article for reply. Upon acceptance, both letters will be published 
online only.  
MANUSCRIPT SUBMISSION On-line Manuscript Submission  
All manuscripts must be submitted on-line through http://jpo.edmgr.com/. First-time users: 
Please click the Register button from the main menu and enter the requested information. On 
successful registration, you will be sent an e-mail indicating your user name and password. Print a 
copy of this information for future reference. Note: If you have received an e-mail from us with an 
assigned user ID and password, or if you are a repeat user, do not register again. Just log in. Once 
you have an assigned ID and password, you do not have to re-register, even if your status 
changes (that is, author, reviewer, or editor). Authors: Please click the log-in button from the 
menu at the top of the page and log in to the system as an Author. Submit your manuscript 
according to the author instructions. You will be able to track the progress of your manuscript 
through the system. If you experience any problems, please contact the Editorial Office e-
mail:pregis@lww.com, telephone: (360) 297-8698, fax: (360) 297-8697. Requests for help and 
other questions will be addressed in the order received.  
PREPARATION OF MANUSCRIPT  
Manuscripts that do not adhere to the following instructions will be returned to the corresponding 
author for technical revision before undergoing peer review.  
Title Page 
The title page must be submitted as a separate file. Include on the title page (a) complete 
manuscript title; (b) authors' full names, highest academic degrees, and affiliations; (c) name and 
address for correspondence, including fax number, telephone number, and e-mail address; (d) 
address for reprints if different from that of corresponding author; and (e) all sources of support, 
including pharmaceutical and industry support, that require acknowledgment.  
 
The title page must also include disclosure of funding received for this work from any of the 
following organizations: National Institutes of Health (NIH); Wellcome Trust; Howard Hughes 
Medical Institute (HHMI); and other(s).  
Structured Abstract and Levels of Evidence 
A structured abstract of no more than 325 words, consisting of five paragraphs, with the headings 
Background (which states the primary research question), Methods, Results, Conclusions, and 
Level of Evidence (for clinical articles) or Clinical Relevance (for basic-science articles).Limit the 
use of abbreviations and acronyms. For the Level of Evidence section, describe the study type and 
assign a level-of-evidence rating to the primary research question, according to the criteria in the 




Levels of Evidence for Primary Research Question1 
   Types of Studies 
   
Therapeutic Studies—
Investigating the Results of 
Treatment 
Prognostic Studies—
Investigating the Effect of a 
Patient Characteristic on 
the Outcome of Disease 
Diagnostic Studies—





Economic or Decision 
Model 
Level I  High-quality randomized 
controlled trial with statistically 
significant difference or no 
statistically significant difference 
but narrow confidence intervals  
  Systematic review2 of Level-I 
randomized controlled trials (and 
study results were 
homogeneous3) 
 High-quality prospective 
study4 (all patients were 
enrolled at the same point in 
their disease with ≥80% 
follow-up of enrolled patients) 
  Systematic review2 of 
Level-I studies 
 Testing of previously 
developed diagnostic criteria 
in series of consecutive 
patients (with universally 
applied reference "gold" 
standard)  
  Systematic review2 of 
Level-I studies 
 Sensible costs and 
alternatives; values 
obtained from many 
studies; multiway 
sensitivity analyses  
  Systematic review2 of 
Level-I studies 
Level II  Lesser-quality randomized 
controlled trial (e.g., <80% follow-
up, no blinding, or improper 
randomization)  
  Prospective4 comparative 
study5  
  Systematic review2 of Level-II 
studies or Level-I studies with 
inconsistent results 
 Retrospective6 study  
  Untreated controls from a 
randomized controlled trial  
  Lesser-quality prospective 
study (e.g., patients enrolled 
at different points in their 
disease or <80% follow-up)  
  Systematic review2 of 
Level-II studies 
 Development of diagnostic 
criteria on basis of 
consecutive patients (with 
universally applied reference 
"gold" standard)  
  Systematic review2 of 
Level-II studies 
 Sensible costs and 
alternatives; values 
obtained from limited 
studies; multiway 
sensitivity analyses  
  Systematic review2 of 
Level-II studies 
Level III  Case-control study7  
  Retrospective6 comparative 
study5  
  Systematic review2 of Level-III 
studies 
 Case-control study7  Study of nonconsecutive 
patients (without consistently 
applied reference "gold" 
standard)  
  Systematic review2 of 
Level-III studies 
 Analyses based on 
limited alternatives and 
costs; poor estimates  
  Systematic review2 of 
Level-III studies 
Level IV Case series8 Case series  Case-control study  
  Poor reference standard 
 No sensitivity 
analyses 
Level V Expert opinion Expert opinion Expert opinion Expert opinion 
1.        A complete assessment of the quality of individual studies requires critical appraisal of all aspects of the study design.  
2.        A combination of results from two or more prior studies.  




4.        Study was started before the first patient enrolled.  
5.        Patients treated one way (e.g., with cemented hip arthroplasty) compared with patients treated another way (e.g., with 
cementless hip arthroplasty) at the same institution.  
6.        Study was started after the first patient enrolled.  
7.        Patients identified for the study on the basis of their outcome (e.g., failed total hip arthroplasty), called "cases," are compared 
with those who did not have the outcome (e.g., had a successful total hip arthroplasty), called "controls."  
8.        Patients treated one way with no comparison group of patients treated another way. 
This chart is reprinted from The Journal of Bone and Joint Surgery. 
Text 
Each manuscript page must be numbered clearly, with line numbers continuing throughout. 
Organize the manuscript into four main headings: 
Introduction, Materials and Methods, Results, and Discussion. Define abbreviations at first mention 
in text and in each table and figure. If a brand name is cited, supply the manufacturer's name and 
address (city and state/country).  
Abbreviations 
For a list of standard abbreviations, consult the Council of Biology Editors Style Guide (available 
from the Council of Science Editors, 9650 Rockville Pike, Bethesda, MD 20814) or other standard 
sources. Write out the full term for each abbreviation at its first use unless it is a standard unit of 
measure.  
References 
The authors are responsible for the accuracy of the references. Key the references (double-
spaced) at the end of the manuscript. Cite the references in text in the order of appearance. Cite 
unpublished data—such as papers submitted but not yet accepted for publication and personal 
communications, including e-mail communications—in parentheses in the text. If there are more 
than three authors, name only the first three authors and then use et al. Refer to the List of 
Journals Indexed in Index Medicus for abbreviations of journal names, or access the list at 
http://www.nlm.nih.gov/tsd/serials/lji.html. Sample references are given below:  
 
Journal article  
1. Rand NS, Dawson JM, Juliao SF, et al. In vivo macrophage recruitment by murine 
intervertebral disc cells. J Spinal Disord. 2001;14:339-342.  
 
Book chapter  
2. Todd VR. Visual information analysis: frame of reference for visual perception. In: 
Kramer P, Hinojosa J, eds. Frames of Reference for Pediatric Occupational Therapy. 
Philadelphia, PA: Lippincott Williams & Wilkins; 1999:205-256.  
 
Entire book  
3. Kellman RM, Marentette LJ. Atlas of Craniomaxillofacial Fixation.Philadelphia, PA: 






4. Epi Info [computer program]. Version 6. Atlanta, GA: Centers for Disease Control and 
Prevention; 1994.  
 
Online journals  
5. Friedman SA. Preeclampsia: a review of the role of prostaglandins. Obstet Gynecol 
[serial online]. January 1988;71:22-37. Available from: BRS Information Technologies, 
McLean, VA. Accessed December 15, 1990.  
 
Database  
6. CANCERNET-PDQ [database online]. Bethesda, MD: National Cancer Institute; 1996. 
Updated March 29, 1996.  
 
World Wide Web  
7. Gostin LO. Drug use and HIV/AIDS [JAMA HIV/AIDS Web site]. June 1, 1996. 
Available at: http://www.ama-assn.org/special/hiv/ethics. Accessed June 26, 1997.  
Figures:  
A) Creating Digital Artwork  
1. Learn about the publication requirements for Digital Artwork: http://links.lww.com/ES/A42  
2. Create, Scan and Save your artwork and compare your final figure to the Digital Artwork 
Guideline Checklist (below).  
3. Upload each figure to Editorial Manager in conjunction with your manuscript text and 
tables.  
B) Digital Artwork Guideline Checklist  
Here are the basics to have in place before submitting your digital artwork:  
 Artwork should be saved as TIFF, EPS, or MS Office (DOC, PPT, XLS) files. High resolution 
PDF files are also acceptable.  
 Crop out any white or black space surrounding the image.  
 Diagrams, drawings, graphs, and other line art must be vector or saved at a resolution of 
at least 1200 dpi. If created in an MS Office program, send the native (DOC, PPT, XLS) file.  
 Photographs, radiographs and other halftone images must be saved at a resolution of at 
least 300 dpi.  
 Photographs and radiographs with text must be saved as postscript or at a resolution of at 
least 600 dpi.  
 Each figure must be saved and submitted as a separate file. Figures should not be 





 Cite figures consecutively in your manuscript.  
 Number figures in the figure legend in the order in which they are discussed.  
 Upload figures consecutively to the Editorial Manager web site and enter figure numbers 
consecutively in the Description field when uploading the files.  
Figure Legends 
Include legends for all figures. They should be brief and specific, and they should appear on a 
separate manuscript page after the references. Use scale markers in the image for electron 
micrographs, and indicate the type of stain used.  
Color Figures 
The journal accepts for publication color figures that will enhance an article. Authors who submit 
color figures will receive an estimate of the cost for color reproduction. If they decide not to pay 
for color reproduction, they can request that the figures be converted to black and white at no 
charge.  
Tables 
Create tables using the table creating and editing feature of your word processing software (eg, 
Word, WordPerfect). Group all tables in a separate file. Cite tables consecutively in the text, and 
number them in that order. Each table should appear on a separate sheet and should include the 
table title, appropriate column heads, and explanatory legends (including definitions of any 
abbreviations used). Do not embed tables within the body of the manuscript. They should be self-
explanatory and should supplement, rather than duplicate, the material in the text.  
Style 
Pattern manuscript style after the American Medical Association Manual of Style (9th edition). 
Stedman's Medical Dictionary (27th edition) and Merriam Webster's Collegiate Dictionary (10th 
edition) should be used as standard references. Refer to drugs and therapeutic agents by their 
accepted generic or chemical names, and do not abbreviate them. Use code numbers only when a 
generic name is not yet available. In that case, supply the chemical name and a figure giving the 
chemical structure of the drug is required. Copyright or trade names of drugs should be capitalized 
and placed in parentheses after the name of the drug. Names and locations (city and state in USA; 
city and country outside USA) of manufacturers of drugs, supplies, or equipment cited in a 
manuscript are required to comply with trademark law and should be provided in parentheses. 
Units of measure should be expressed in the metric system, and temperatures should be 
expressed in degrees Celsius. Conventional units should be written as SI units as appropriate.  
AFTER ACCEPTANCE  
Page Proofs and Corrections  
Corresponding authors will receive electronic page proofs to check the copyedited and typeset 
article before publication. Portable document format (PDF) files of the typeset pages and support 
documents (eg, reprint order form) will be sent to the corresponding author by e-mail. Complete 
instructions will be provided with the e-mail for downloading and printing the files and for faxing 
the corrected page proofs to the publisher. Those authors without an e-mail address will receive 
traditional page proofs. It is the author's responsibility to ensure that there are no errors in the 
proofs. Changes that have been made to conform to journal style will stand if they do not alter the 
authors' meaning. Only the most critical changes to the accuracy of the content will be made. 
Changes that are stylistic or are a reworking of previously accepted material will be disallowed. 
53 
The publisher reserves the right to deny any changes that do not affect the accuracy of the 
content. Authors may be charged for alterations to the proofs beyond those required to correct 
errors or to answer queries. Proofs must be checked carefully and corrections faxed within 24 to 
48 hours of receipt, as requested in the cover letter accompanying the page proofs. 
Reprints 
Authors will receive a reprint order form and a price list with the page proofs. Reprint requests 
should be faxed to the publisher with the corrected proofs, if possible. Reprints are normally 
shipped 6 to 8 weeks after publication of the issue in which the item appears. Contact the Reprint 
Department, Lippincott Williams & Wilkins, 530 Walnut Street, Philadelphia, PA 19106 with any 
questions. 
Publisher's Contact 
Fax corrected page proofs, reprint order form, and any other related materials to Journal 
Production Editor, Journal of Pediatric Orthopaedics (443) 817-0913. Color proofs should be 
returned to Journal Production Editor, Journal of Pediatric Orthopaedics, Lippincott Williams & 
Wilkins, 351 West Camden Street, Baltimore, MD 21201. 
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